July 5, 2017 – Top Stories
Update: MMWR Publication on Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine
Summit’s NEW Coding and Billing Resource Is Live
Eculizumab Patients at High Risk for Meningococcal Disease Despite Vaccination
